Overview of hemophilia treatment classes | February 27, 2024

Listen to this free 90-minute webinar covering the different aspects and applications of factor and non-factor hemophilia treatments, such as standard half-life (SHL), extended half-life (EHL), bispecific antibody, and rebalancing agent products, and gene therapy.
Speakers for the session will include Glenn Pierce, MD, PhD, Vice President, Medical, WFH; Barbara Konkle, MD, WFH Board Member; and Steven Pipe, MD. Participants will also have the opportunity to hear testimonials from people with hemophilia, Enrique Preza and Hazri Aris, who have made treatment changes.
Visit eLearning.wfh.org for more resources and materials for bleeding disorders from the World Federation of Hemophilia.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions. The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.